Vadim Markovtsov

2.1k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Vadim Markovtsov is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Vadim Markovtsov has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Genetics. Recurrent topics in Vadim Markovtsov's work include RNA and protein synthesis mechanisms (9 papers), Platelet Disorders and Treatments (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Vadim Markovtsov is often cited by papers focused on RNA and protein synthesis mechanisms (9 papers), Platelet Disorders and Treatments (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Vadim Markovtsov collaborates with scholars based in United States, United Kingdom and Germany. Vadim Markovtsov's co-authors include Douglas L. Black, Alex Goldfarb, Arkady Mustaev, Joseph Goldman, Julia Nikolic, Min‐Yuan Chou, Christoph W. Turck, Evgeny Nudler, Nichola Cooper and Vadim Nikiforov and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Vadim Markovtsov

25 papers receiving 1.5k citations

Hit Papers

Fostamatinib for the treatment of adult persistent and ch... 2018 2026 2020 2023 2018 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
    2018 237 citations James B. Bussel, Donald M. Arnold et al. American Journal of Hematology profile →

Peers

Vadim Markovtsov
Gustavo Leone United States
Claudia Schneider United Kingdom
Hein Schepers Netherlands
Gianmarco Corneo Italy
Lyndal K. Hesterberg United States
Sanchari Bhattacharyya United States
Javier Lizardi Cervera Spain
Y Mory Israel
Bruce J. Dolnick United States
Neng‐Yao Shih Taiwan
Gustavo Leone United States
Vadim Markovtsov
Citations per year, relative to Vadim Markovtsov Vadim Markovtsov (= 1×) peers Gustavo Leone

Countries citing papers authored by Vadim Markovtsov

Since Specialization
Citations

This map shows the geographic impact of Vadim Markovtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vadim Markovtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vadim Markovtsov more than expected).

Fields of papers citing papers by Vadim Markovtsov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vadim Markovtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vadim Markovtsov. The network helps show where Vadim Markovtsov may publish in the future.

Co-authorship network of co-authors of Vadim Markovtsov

This figure shows the co-authorship network connecting the top 25 collaborators of Vadim Markovtsov. A scholar is included among the top collaborators of Vadim Markovtsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vadim Markovtsov. Vadim Markovtsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammouda, M. Ben, Wanying Miao, Yingai J. Jin, et al.. (2024). UBE2N Is Essential for Maintenance of Skin Homeostasis and Suppression of Inflammation. Journal of Investigative Dermatology. 144(12). 2742–2753. 2 indexed citations
2.
Markovtsov, Vadim, Matthew A. J. Duncton, Sothy Yi, et al.. (2023). Tuning the Reactivity of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Optimal in Vivo Efficacy. ACS Medicinal Chemistry Letters. 14(12). 1700–1706. 2 indexed citations
3.
Malik, Anuj, et al.. (2023). 88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
4.
Shaw, Simon J., Dane A. Goff, Rajinder Singh, et al.. (2023). Optimization of Pharmacokinetic and In Vitro Safety Profile of a Series of Pyridine Diamide Indirect AMPK Activators. Journal of Medicinal Chemistry. 66(24). 17086–17104. 6 indexed citations
5.
Shaw, Simon J., Dane A. Goff, D. C. Carroll, et al.. (2022). Structure activity relationships leading to the identification of the indirect activator of AMPK, R419. Bioorganic & Medicinal Chemistry. 71. 116951–116951. 2 indexed citations
6.
Cooper, Nichola, Waleed Ghanima, Quentin A. Hill, et al.. (2022). Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib. Platelets. 34(1). 2131751–2131751. 43 indexed citations
7.
Markovtsov, Vadim, Sothy Yi, & Esteban S. Masuda. (2022). SYK Kinase As a Master Regulator of Netosis. Blood. 140(Supplement 1). 8323–8324.
8.
Cooper, Nichola, Ivy Altomare, Mark R. Thomas, et al.. (2021). Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib. Therapeutic Advances in Hematology. 12. 1543928635–1543928635. 32 indexed citations
9.
Dummer, Wolfgang, Vadim Markovtsov, Sandra Tong, & Esteban S. Masuda. (2020). Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications. Blood. 136(Supplement 1). 35–35. 2 indexed citations
10.
Altomare, Ivy, Vadim Markovtsov, Leslie Todd, et al.. (2019). Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia. Blood. 134(Supplement_1). 4889–4889. 4 indexed citations
11.
Bussel, James B., Donald M. Arnold, Jiřı́ Mayer, et al.. (2018). Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. American Journal of Hematology. 93(7). 921–930. 237 indexed citations breakdown →
12.
13.
Hitoshi, Yasumichi, Nan Lin, Donald G. Payan, & Vadim Markovtsov. (2010). The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases. International Journal of Hematology. 91(2). 189–200. 23 indexed citations
14.
Shide, Kotaro, Takuro Kameda, Vadim Markovtsov, et al.. (2009). Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2V617F-Induced Murine MPD Model.. Blood. 114(22). 3897–3897. 9 indexed citations
15.
Boutz, Paul L., et al.. (2005). Exon repression by polypyrimidine tract binding protein. RNA. 11(5). 699–716. 98 indexed citations
16.
Grachev, M.A., М. В. Козлов, Konstantin Severinov, et al.. (2003). Strategies and Methods of Cross-Linking of RNA Polymerase Active Center. Methods in enzymology on CD-ROM/Methods in enzymology. 371. 191–206. 9 indexed citations
17.
Markovtsov, Vadim, et al.. (2003). Roles for SR Proteins and hnRNP A1 in the Regulation of c -src Exon N1. Molecular and Cellular Biology. 23(6). 1874–1884. 76 indexed citations
18.
Mustaev, Arkady, et al.. (2002). Swing-Gate Model of Nucleotide Entry into the RNA Polymerase Active Center. Molecular Cell. 10(3). 623–634. 71 indexed citations
19.
Markovtsov, Vadim, Julia Nikolic, Joseph Goldman, et al.. (2000). Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding Protein. Molecular and Cellular Biology. 20(20). 7463–7479. 265 indexed citations
20.
Zaychikov, Evgeny, Emil Martin, М. В. Козлов, et al.. (1996). Mapping of Catalytic Residues in the RNA Polymerase Active Center. Science. 273(5271). 107–109. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustavo Leone Breakdown of academic impact, for papers by Claudia Schneider Breakdown of academic impact, for papers by Hein Schepers Breakdown of academic impact, for papers by Gianmarco Corneo Breakdown of academic impact, for papers by Lyndal K. Hesterberg Breakdown of academic impact, for papers by Sanchari Bhattacharyya Breakdown of academic impact, for papers by Javier Lizardi Cervera Breakdown of academic impact, for papers by Y Mory Breakdown of academic impact, for papers by Bruce J. Dolnick Breakdown of academic impact, for papers by Neng‐Yao Shih
Rankless by CCL
2026